Bente Vinda

Ultimovacs logo
19th August 2016
WATRIUM ENTERS ULTIMOVACS

Watrium invests to become a shareholder of Ultimovacs, a pharmaceutical company developing novel immunotherapy against cancer. Its leading product is UV1, a therapeutic cancer vaccine directed against human telomerase. Watrium’s...

Continue Reading
Fornebu Gateway, image: fornebuporten.no
28th October 2015
INVESTS IN FORNEBU OFFICE ASSETS

Watrium invests in a 20 percent ownership share in Fornebu Gateway AS, which owns two ultra-modern office buildings at Fornebu outside Oslo. The buildings have lease contract durations of around...

Continue Reading